Australian Pharmaceutical Industries Ltd
ASX:API

Watchlist Manager
Australian Pharmaceutical Industries Ltd Logo
Australian Pharmaceutical Industries Ltd
ASX:API
Watchlist
Price: 1.53 AUD
Market Cap: 753.8m AUD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

API price has not been updated for more than 9 months. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the relative value of API.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

API Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
vs Industry
Median 3Y
0.2
Median 5Y
0.2
Industry
2.3
Forward
0.3
More Details
547.4
P/E
P/E
Price to Earnings
547.4
vs History
vs Industry
Median 3Y
547.4
Median 5Y
547.4
Industry
22
Forward
26.1
More Details
10.5
P/OCF
P/OCF
Price to OCF
10.5
vs History
vs Industry
Median 3Y
10.5
Median 5Y
10.5
Industry
14.2
More Details
102.6
P/FCFE
P/FCFE
Price to FCFE
102.6
vs History
vs Industry
Median 3Y
102.7
Median 5Y
102.7
Industry
19.9
More Details
1.7
P/B
P/B
Price to Book Value
1.7
vs History
vs Industry
Median 3Y
1.7
Median 5Y
1.7
Industry
2.2
More Details
0.2
EV/S
EV/S
Enterprise Value to Sales
0.2
vs History
vs Industry
Median 3Y
0.3
Median 5Y
0.3
Industry
2.4
Forward
0.4
More Details
2
EV/GP
EV/GP
Enterprise Value to Gross Profit
2
vs History
vs Industry
Median 3Y
2
Median 5Y
2
Industry
4.9
More Details
41.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
41.1
vs History
vs Industry
Median 3Y
41.1
Median 5Y
41.1
Industry
11.6
More Details
41.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
41.1
vs History
vs Industry
Median 3Y
41.1
Median 5Y
41.1
Industry
15.9
More Details
13.7
EV/OCF
EV/OCF
Enterprise Value to OCF
13.7
vs History
vs Industry
Median 3Y
13.7
Median 5Y
13.7
Industry
14.2
More Details
37.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
37.9
vs History
vs Industry
Median 3Y
37.9
Median 5Y
37.9
Industry
17.8
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
vs Industry
Median 3Y
0.7
Median 5Y
0.7
Industry
1.8
More Details

Multiples Across Competitors

API Competitors Multiples
Australian Pharmaceutical Industries Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Australian Pharmaceutical Industries Ltd
ASX:API
753.8m AUD 0.2 547.4 41.1 41.1
US
Mckesson Corp
NYSE:MCK
91.9B USD 0.3 27.9 17.9 20.5
US
Cencora Inc
NYSE:COR
58.6B USD 0.2 34.6 14.8 20
US
Amerisourcebergen Corp
LSE:0HF3
58B USD 0.2 34.2 14.7 19.8
US
Cardinal Health Inc
NYSE:CAH
40.1B USD 0.2 25.7 13.9 18.3
AU
Sigma Healthcare Ltd
ASX:SIG
34.9B AUD 7.1 -2 514.4 1 614.7 1 614.7
CN
Huadong Medicine Co Ltd
SZSE:000963
69.5B CNY 1.6 19.3 15.3 15.3
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
66.6B CNY 0.2 15.3 10.3 10.3
US
Henry Schein Inc
NASDAQ:HSIC
9B USD 0.7 22.1 10.9 15
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
AU
EBOS Group Ltd
OTC:EBOSY
8.2B USD 1 51.1 30.5 30.5

See Also

Summary
API intrinsic value, competitors valuation, and company profile.
DCF Valuation
API stock valuation using Discount Cash Flow valuation method.
Relative Valuation
API stock valuation using valuation multiples.
Wall Street Estimates
API price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
API stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 266,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.